Effects of luteal estradiol pre-treatment on the outcome of IVF in poor ovarian responders

References

• Garcia JE, Jones GS, Acosta AA, Wright G. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981. Fertil Steril 1983;39:174–179.
   PubMed Web of Science ®Google Scholar
• Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521–527.
   PubMedGoogle Scholar
• Turhan NO. Poor response–the devil is in the definition. Fertil Steril 2006;86:777; author reply 777.
   Google Scholar
• Mahutte NG, Arici A. Poor responders: does the protocol make a difference? Curr Opin Obstet Gynecol 2002;14:275–281.
   PubMed Web of Science ®Google Scholar
• Olivennes F, Cunha-Filho JS, Fanchin R, Bouchard P, Frydman R. The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 2002;8:279–290.
   PubMed Web of Science ®Google Scholar
• Lamazou F, Fuchs F, Grynberg M, Gallot V, Herzog E, Fanchin R, Frydman N, Frydman R. [Cancellation of IVF-ET cycles: poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? An analysis of 142 cancellations]. J Gynecol Obstet Biol Reprod (Paris) 2012;41:41–47.
   PubMed Web of Science ®Google Scholar
• Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001;16:868–870.
   PubMed Web of Science ®Google Scholar
• Huirne JAF, van Loenen ACD, Donnez J, Pirard C, Homburg R, Schats R, McDonnell J, Lambalk CB. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod Biomed Online 2006;13:235–245.
   PubMed Web of Science ®Google Scholar
• Horvath PM, Styler M, Hammond JM, Shelden RM, Kemmann E. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 1988;49:159–162.
   PubMed Web of Science ®Google Scholar
• Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 2006;21:352–357.
   PubMed Web of Science ®Google Scholar
• Schachter M, Friedler S, Raziel A, Strassburger D, Bern O, Ron-el R. Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase–a function of improved embryo quality. J Assist Reprod Genet 2001;18:197–204.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Salomon L, Castelo-Branco A, Olivennes F, Frydman N, Frydman R. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 2003;18:2698–2703.
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Jääskeläinen AS, Brioschi PA, Fanchin R, Bulletti C. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod 1998;13:561–564.
   PubMed Web of Science ®Google Scholar
• Dragisic KG, Davis OK, Fasouliotis SJ, Rosenwaks Z. Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril 2005;84:1023–1026.
   PubMed Web of Science ®Google Scholar
• Frattarelli JL, Hill MJ, McWilliams GD, Miller KA, Bergh PA, Scott RTJr. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril 2008;89:1118–1122.
   PubMed Web of Science ®Google Scholar
• Chang EM, Han JE, Won HJ, Kim YS, Yoon TK, Lee WS. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization. J Assist Reprod Genet 2012;29:225–230.
   PubMed Web of Science ®Google Scholar
• Shastri SM, Barbieri E, Kligman I, Schoyer KD, Davis OK, Rosenwaks Z. Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide. Fertil Steril 2011;95:592–595.
   PubMed Web of Science ®Google Scholar
• Ata B, Zeng X, Son WY, Holzer H, Tan SL. Follicular synchronization using transdermal estradiol patch and GnRH antagonists in the luteal phase; does it increase oocyte yield in poor responders to gonadotropin stimulation for in vitro fertilization (IVF)? A comparative study with microdose flare-up protocol. Gynecol Endocrinol 2011;27:876–879.
   PubMed Web of Science ®Google Scholar
• Hill MJ, McWilliams GD, Miller KA, Scott RT, Frattarelli JL. A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates. Fertil Steril 2009;91:739–743.
   PubMed Web of Science ®Google Scholar
• Weitzman VN, Engmann L, DiLuigi A, Maier D, Nulsen J, Benadiva C. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Fertil Steril 2009;92:226–230.
   PubMed Web of Science ®Google Scholar
• Takekida S, Matsuo H, Maruo T. GnRH agonist action on granulosa cells at varying follicular stages. Mol Cell Endocrinol 2003;202:155–164.
   PubMedGoogle Scholar
• Yang BC, Uemura T, Minaguchi H. Effects of a gonadotropin releasing hormone agonist on oocyte maturation, fertilization, and embryonal development of mice. J Assist Reprod Genet 1995;12:728–732.
   PubMedGoogle Scholar
• Yoshimura Y, Nakamura Y, Ando M, Shiokawa S, Koyama N, Nanno T. Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle. Fertil Steril 1992;57:1091–1097.
   PubMedGoogle Scholar
• Fanchin R, Cunha-Filho JS, Schonäuer LM, Righini C, de Ziegler D, Frydman R. Luteal estradiol administration strengthens the relationship between day 3 follicle-stimulating hormone and inhibin B levels and ovarian follicular status. Fertil Steril 2003;79:585–589.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Cunha-Filho JS, Schonäuer LM, Kadoch IJ, Cohen-Bacri P, Frydman R. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens. Fertil Steril 2003;79:316–321.
   PubMed Web of Science ®Google Scholar
• Battaglia C, Salvatori M, Maxia N, Petraglia F, Facchinetti F, Volpe A. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod 1999;14:1690–1697.
   PubMed Web of Science ®Google Scholar
• Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61–76.
   PubMed Web of Science ®Google Scholar
• Dor J, Seidman DS, Ben-Shlomo I, Levran D, Karasik A, Mashiach S. The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment. J Assist Reprod Genet 1992;9:228–232.
   PubMedGoogle Scholar
• Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65:961–965.
   PubMed Web of Science ®Google Scholar
• Spandorfer S, Navarro J, Kump LM, Liu HC, Davis OK, Rosenwaks Z. “Co-Flare” stimulation in the poor responder patient: predictive value of the flare response. J Assist Reprod Genet 2001;18:629–633.
   PubMed Web of Science ®Google Scholar
• Ulug U, Ben-Shlomo I, Turan E, Erden HF, Akman MA, Bahceci M. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online 2003;6:439–443.
   PubMedGoogle Scholar
• Kailasam C, Keay SD, Wilson P, Ford WC, Jenkins JM. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod 2004;19:1544–1547.
   PubMed Web of Science ®Google Scholar
• Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered ‘difficult responders’ to GnRH agonist protocols? Hum Reprod 1999;14:2959–2962.
   PubMed Web of Science ®Google Scholar
• Nikolettos N, Al-Hasani S, Felberbaum R, Demirel LC, Kupker W, Montzka P, Xia YX, et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol 2001;97:202–207.
   PubMed Web of Science ®Google Scholar
• Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874–885.
   PubMed Web of Science ®Google Scholar